General Archive
-
News releasesDementia Consortium signs new pharmaceutical partner AbbVie
The Dementia Consortium has welcomed AbbVie as new pharmaceutical partner, joining medical research charity MRC Technology, Alzheimer’s Research UK, the…
-
News releases
New UK-USA collaboration aims to translate more basic research into Alzheimer’s disease treatments
Partnership between MRC Technology and Alzheimer’s Association will focus on finding new ways to translate fundamental research findings into new…
-
News releases
Charity seeks diagnostic partners to deliver new patient treatments
MRC Technology has launched a Call for Diagnostics. It is seeking academic and industry collaborators to develop diagnostic tests in…
-
News releases
MRC Technology strengthens its collaborative relationships in Scandinavia
MRC Technology (MRCT) and the University of Turku (UTU, Finland) have signed a memorandum of understanding outlining how they will…
-
News releases
Dementia Consortium signs new pharma partner Astex Pharmaceuticals
The Dementia Consortium, a unique charity-private partnership, today announced Astex Pharmaceuticals (Astex) as a new member.
-
News releases
Charity and academic collaboration aims to find drug treatment for lymphoma
MRC Technology and the University of Lausanne are collaborating to find new drug treatments for diffuse large B cell lymphoma,…
-
News releases
EU Consortium receives funding for detection and prevention of diseases associated with ageing
Marie Skłodowska-Curie actions has awarded €2,887,054.24 to an EU consortium, including MRC Technology, to provide training for 11 young researchers…
-
News releases
Dementia Consortium funds project focusing on ALS and FTLD
A project to identify new agents capable of stimulating clearance of a protein that forms aggregates in neurons of patients…
-
News releases
NICE recommends pembrolizumab made available on the NHS for advanced skin cancer (antibody humanized by MRC Technology)
Pembrolizumab, an immunotherapy treatment for advanced melanoma (skin cancer), was approved by “The National Institute for Health and Care Excellence…
-
News releases
Georg-August-University Göttingen, Universitätsmedizin and MRC Technology collaborate to develop new therapy for neurodegenerative diseases
Georg-August-University Göttingen (UMG) and MRC Technology (MRCT) have signed a collaboration agreement for the development of a novel therapy for…
-
News releases
Keytruda receives EU marketing approval (antibody humanised by MRC Technology)
Keytruda receives European Commission approval for treatment of advanced melanoma in all EU member states.
-
News releases
MRC Technology appoints technology transfer director
Andrew Farquharson has been appointed Director of Technology Transfer from 1 September.